Efficacy of an LED Mask
Public ClinicalTrials.gov record NCT07890233. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
12-week Study Evaluating the Efficacy of an LED Mask
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this interventional study is to evaluate the efficacy and perception a commercial LED device in 110 healthy adult females and males between the ages of 35-65 years old, inclusively. The main questions it aims to answer are: Does daily use of this commercial LED device improve overall skin appearance as measured by clinical tools (expert clinical grading, cutometer, digital photography, and VISIA-CR? Does daily use of this commercial LED device improve subjective skin appearance? Is daily use of this commercial LED device well tolerated? Participants will complete a 9-minute LED treatment (4.5 minutes LED, 4.5 minutes LED+ infrared light therapy) with a commercially available device every day for 12 weeks. They will visit the clinic three times (baseline, 6 weeks, 12 weeks) for clinical grading of skin.
Study identification
- NCT ID
- NCT07890233
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 25 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2026 (Estimated)
- Primary completion
- Mar 30, 2027 (Estimated)
- Completion
- May 31, 2027 (Estimated)
- Last update posted
- Oct 22, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ALS Global Clinical Studies | Purchase | New York | 10577 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07890233, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 22, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07890233 live on ClinicalTrials.gov.